| Type | Period | Ended | Filed | |
|---|---|---|---|---|
| 10-Q | Q3 2024 | 9/30/24 | 11/5/24 | → |
| 10-K/A | FY 2024 | 6/30/24 | 10/25/24 | → |
| 10-K | FY 2024 | 6/30/24 | 9/6/24 | → |
| 10-Q | Q1 2024 | 3/31/24 | 5/8/24 | → |
| 10-Q | Q4 2023 | 12/31/23 | 2/14/24 | → |
| 10-Q | Q3 2023 | 9/30/23 | 12/8/23 | → |
| ↓ | ||||
| Filed | Period | |
|---|---|---|
| 11/5/24 | Q2 FY2025 | → |
| 8/29/24 | Q1 FY2025 | → |
| 5/8/24 | Q4 FY2024 | → |
| 2/9/24 | Q3 FY2024 | → |
| 12/8/23 | Q2 FY2024 | → |
| 11/15/23 | Q2 FY2024 | → |
| ↓ | ||
| Filed | Type | Description | |
|---|---|---|---|
| 12/18/24 | Delisting | Termination of a Material Definitive Agreement | → |
| 12/16/24 | Other | Other Events | → |
| 12/6/24 | Other | Other Events | → |
| 10/21/24 | Other | Other Events | → |
| 5/29/24 | Exec Change | Departure or Appointment of Directors or Certain Officers | → |
| 5/16/24 | Other | Other Events | → |
| ↓ | |||
| Filed | Form | Description | |
|---|---|---|---|
| 12/18/24 | POSASR | POSASR | → |
| 12/18/24 | S-8 POS | S-8 POS | → |
| 12/18/24 | S-8 POS | S-8 POS | → |
| 12/18/24 | S-8 POS | S-8 POS | → |
| 4/9/24 | S-8 | S-8 | → |
| 12/15/23 | ARS | ARS | → |
| ↓ | |||
| Filed | Form | Description | |
|---|---|---|---|
| 5/16/24 | DEFA14A | DEFA14A | → |
| 5/3/24 | DEFA14A | DEFA14A | → |
| 4/22/24 | DEFA14A | DEFA14A | → |
| 4/15/24 | DEFM14A | DEFM14A | → |
| 4/3/24 | PREM14A | PREM14A | → |
| 2/6/24 | DEFA14A | DEFA14A | → |
| ↓ | |||
| Filed | Form | Description | |
|---|---|---|---|
| 12/18/24 | 4 | 4 | → |
| 12/18/24 | 4 | 4 | → |
| 12/18/24 | 4 | 4 | → |
| 12/18/24 | 4 | 4 | → |
| 12/18/24 | 4 | 4 | → |
| 12/18/24 | 4 | 4 | → |
| ↓ | |||
| Filed | Form | Description | |
|---|---|---|---|
| 12/30/24 | 15-12G | 15-12G | → |
| 12/18/24 | 25-NSE | 25-NSE | → |
| 11/12/24 | 144 | 144 | → |
| 10/18/24 | 144 | 144 | → |
| 10/16/24 | 144 | 144 | → |
| 9/26/24 | 144 | 144 | → |
| ↓ | |||
It operates as an privately held independent subsidiary of Novo Holdings A/S. It is a provider of drug delivery technologies, drug development, drug manufacturing, biologics, gene therapy, and consumer health products.